Novo Holdings A/S Long-Term Concentrated

CIK: 0001388325 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Nov 14, 2023

Total Value ($000): $1,353,230 (100.0% shares, 0.0% debt)

Holdings (40)

BN BROOKFIELD CORP 9.0%
Value ($000) $121,335 Shares 3,880,230 Est. Cost $22.16 Unrealized 0.0%
ASML ASML HOLDING N V 8.6%
Value ($000) $116,413 Shares 197,760 Est. Cost $654.82 Unrealized
CRM SALESFORCE.COM, INC. 7.9%
Value ($000) $107,575 Shares 530,500 Est. Cost $193.03 Unrealized +10.6%
CORT CORCEPT THERAPEUTICS INC 6.8%
Value ($000) $92,044 Shares 3,377,768 Est. Cost $23.02 Unrealized +25.8%
LANZATECH GLOBAL INC 5.5%
Value ($000) $73,855 Shares 15,814,845 Est. Cost $3.88 Unrealized
CABO CABLE ONE INC 5.4%
Value ($000) $72,894 Shares 118,403 Est. Cost $987.67 Unrealized -36.5%
TSM TAIWAN SEMICONDUCTOR MFG LTD 4.6%
Value ($000) $61,767 Shares 710,780 Est. Cost $96.28 Unrealized
IRON DISC MEDICINE, INC. 3.8%
Value ($000) $51,244 Shares 1,090,772 Est. Cost $49.79 Unrealized +0.5%
MIRM MIRUM PHARMACEUTICALS INC 3.5%
Value ($000) $47,400 Shares 1,500,000 Est. Cost $12.27 Unrealized +123.2%
BABA ALIBABA GROUP HLDG LTD 3.2%
Value ($000) $43,442 Shares 500,827 Est. Cost $165.09 Unrealized
PCVX VAXCYTE INC 3.2%
Value ($000) $43,078 Shares 845,000 Est. Cost $26.47 Unrealized +86.4%
ACLX ARCELLX, INC. 2.9%
Value ($000) $38,571 Shares 1,075,000 Est. Cost $17.96 Unrealized +92.0%
AAPL APPLE INC 2.8%
Value ($000) $37,916 Shares 221,460 Est. Cost $90.57 Unrealized +100.2%
BMRN BIOMARIN PHARMACEUTICAL INC 2.6%
Value ($000) $35,392 Shares 400,000 Est. Cost $83.79 Unrealized +6.2%
EWTX EDGEWISE THERAPEUTICS INC 2.6%
Value ($000) $34,791 Shares 6,071,703 Est. Cost $30.65 Unrealized -77.8%
SEAGEN INC. 2.5%
Value ($000) $33,941 Shares 159,986 Est. Cost $141.01 Unrealized
INSM INSMED INC 2.5%
Value ($000) $33,817 Shares 1,339,304 Est. Cost $23.10 Unrealized -1.0%
CRNX CRINETICS PHARMACEUTICALS IN 2.4%
Value ($000) $32,714 Shares 1,100,000 Est. Cost $19.36 Unrealized +6.4%
PHVS PHARVARIS N V 2.1%
Value ($000) $27,743 Shares 1,329,325 Est. Cost $11.67 Unrealized +58.0%
BLUEPRINT MEDICINES CORP 1.9%
Value ($000) $26,366 Shares 525,000 Est. Cost $59.75 Unrealized
FOLD AMICUS THERAPEUTICS INC 1.9%
Value ($000) $25,486 Shares 2,095,900 Est. Cost $13.12 Unrealized -1.7%
RENEO PHARMACEUTICALS INC 1.9%
Value ($000) $25,344 Shares 3,330,377 Est. Cost $9.33 Unrealized
CYMABAY THERAPEUTICS INC 1.7%
Value ($000) $23,357 Shares 1,566,521 Est. Cost $10.95 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 1.5%
Value ($000) $20,966 Shares 118,383 Est. Cost $160.04 Unrealized +19.4%
BAM BROOKFIELD ASSET MANAGMT LTD 1.5%
Value ($000) $20,911 Shares 627,207 Est. Cost $31.11 Unrealized 0.0%
RCKT ROCKET PHARMACEUTICALS INC 1.5%
Value ($000) $20,510 Shares 1,001,000 Est. Cost $28.64 Unrealized -36.5%
FDMT 4D MOLECULAR THERAPEUTICS IN 1.1%
Value ($000) $15,276 Shares 1,200,000 Est. Cost $18.73 Unrealized -10.7%
SPRUCE BIOSCIENCES INC 1.1%
Value ($000) $15,192 Shares 6,722,336 Est. Cost $17.05 Unrealized
INSP INSPIRE MED SYS INC 0.9%
Value ($000) $11,906 Shares 60,000 Est. Cost $206.06 Unrealized +22.4%
IOBT IO BIOTECH INC 0.6%
Value ($000) $8,103 Shares 5,747,067 Est. Cost $6.26 Unrealized -71.9%
RALLYBIO CORP 0.5%
Value ($000) $7,374 Shares 2,187,999 Est. Cost $6.73 Unrealized
ABCL ABCELLERA BIOLOGICS INC 0.4%
Value ($000) $5,184 Shares 1,126,915 Est. Cost $8.47 Unrealized -28.2%
SILK RD MED INC 0.4%
Value ($000) $5,005 Shares 333,884 Est. Cost $41.80 Unrealized
TMCI TREACE MED CONCEPTS INC 0.3%
Value ($000) $4,720 Shares 360,000 Est. Cost $25.28 Unrealized -27.6%
LAVA THERAPEUTICS NV 0.3%
Value ($000) $3,528 Shares 2,400,000 Est. Cost $15.19 Unrealized
MQ MARQETA INC 0.2%
Value ($000) $2,641 Shares 441,558 Est. Cost $22.37 Unrealized -74.6%
CYTEIR THERAPEUTICS INC 0.1%
Value ($000) $1,921 Shares 676,379 Est. Cost $21.40 Unrealized
GALECTO INC 0.1%
Value ($000) $1,798 Shares 2,497,791 Est. Cost $12.51 Unrealized
KINNATE BIOPHARMA INC 0.1%
Value ($000) $1,142 Shares 815,707 Est. Cost $25.36 Unrealized
SPRO SPERO THERAPEUTICS INC 0.0%
Value ($000) $567 Shares 468,902 Est. Cost $11.41 Unrealized -87.9%